Organ Preservation for Cancer of the Larynx: Current Indications and Future Directions

Jill Gilbert, Arlene A. Forastiere

Research output: Contribution to journalArticlepeer-review

Abstract

The optimal regimen for organ preservation for laryngeal cancer remains an area of active investigation. Multiple organ-preservation strategies have been explored, including radiation therapy alone, induction chemotherapy followed by radiation therapy, and concomitant chemoradiotherapy. Until recently, induction chemotherapy followed by radiation therapy was the standard of care for organ preservation in the United States. However, recent data from the Intergroup Trial, R 91-11 has placed concomitant chemoradiotherapy in the forefront as the standard of care for organ preservation. Newer strategies are being investigated and include the use of induction chemotherapy before concomitant chemoradiotherapy and the integration of novel biological agents. It remains to be seen whether such interventions can improve on the excellent locoregional control shown in the landmark Intergroup trial.

Original languageEnglish (US)
Pages (from-to)167-177
Number of pages11
JournalSeminars in Radiation Oncology
Volume14
Issue number2
DOIs
StatePublished - Apr 2004

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Organ Preservation for Cancer of the Larynx: Current Indications and Future Directions'. Together they form a unique fingerprint.

Cite this